FDG ‐ PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FDG ‐ PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer

Published:2013-07-10 Issue:4 Volume:2 Page:545-552
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Chen James L.¹,Appelbaum Daniel E.²,Kocherginsky Masha³,Cowey Charles L.⁴,Kimryn Rathmell Wendy⁵,McDermott David F.⁶,Stadler Walter M.⁷

Affiliation:

1. Departments of Biomedical Informatics and Internal Medicine The Ohio State University Columbus Ohio

2. Department of Radiology The University of Chicago Chicago Illinois

3. Department of Health Studies The University of Chicago Chicago Illinois

4. Texas Oncology, PA Baylor University Medical Center Dallas Texas

5. Department of Medicine University of North Carolina at Chapel Hill Chapel Hill North Carolina

6. Division of Hematology/Oncology Beth Israel Deaconess Medical Center Boston Massachusetts

7. Department of Medicine The University of Chicago Chicago Illinois

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.102

Reference24 articles.

1. Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

2. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

3. Positron Emission Tomography in Renal Cell Carcinoma: An Imaging Biomarker in Development

4. Renal-Cell Carcinoma — Molecular Pathways and Therapies

5. PTEN, pAKT, and pmTOR Expression and Subcellular Distribution in Primary Renal Cell Carcinomas and Their Metastases

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PET/Computed Tomography Transformation of Oncology;PET Clinics;2024-04

2. Biomarkers for the Detection and Surveillance of Renal Cancer;Urologic Clinics of North America;2023-05

3. Molecular and functional imaging in cancer-targeted therapy: current applications and future directions;Signal Transduction and Targeted Therapy;2023-02-27

4. Genitourinary imaging;Clinical PET/MRI;2023

5. Diagnostic Applications of Nuclear Medicine: Kidney and Bladder Cancer;Nuclear Oncology;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3